PharmaShots | Incisive News in 3 Shots

Subscribe Now

Ankylosing Spondylitis

AbbVie's Rinvoq (upadacitinib) Receives the EC's Approval for Psoriatic Arthritis and Ankylosing Spondylitis

AbbVie's Rinvoq (upadacitinib) Receives the EC's Approval for Psoriatic Arthritis and Ankylosing Spondylitis

January 27, 2021

Cadila Launches Cadalimab (biosimilar- adalimumab) in India

Cadila Launches Cadalimab (biosimilar- adalimumab) in India

August 31, 2020

Cadila to Launch its Cadalimab (biosimilar- adalimumab) in India

Cadila to Launch its Cadalimab (biosimilar- adalimumab) in India

August 28, 2020

Celltrion's Remsima SC (biosimilar- infliximab) Receives CHMP's Positive Opinion for an Additional Five Indications Including Inflammatory Bowel Disease and Ankylosing Spondylitis

Celltrion's Remsima SC (biosimilar- infliximab) Receives CHMP's Positive Opinion for an Additional Five Indications Including Infl...

June 30, 2020

AbbVie Reports Results of Rinvoq (upadacitinib) in P-II/III SELECT-AXIS 1 Study for Patients with Ankylosing Spondylitis

AbbVie Reports Results of Rinvoq (upadacitinib) in P-II/III SELECT-AXIS 1 Study for Patients with Ankylosing Spondylitis

November 13, 2019

Lilly Reports Results of Taltz (ixekizumab) in P-III COAST-V and COAST-W trials for Ankylosing Spondylitis (AS)

Lilly Reports Results of Taltz (ixekizumab) in P-III COAST-V and COAST-W trials for Ankylosing Spondylitis (AS)

October 23, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us